Evidence map›Paper›PMID 38786139›Full record

ReviewAntibiotics (Basel, Switzerland)2024

Linking

Irshad Ahmed Hajam, George Y Liu

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Antibiotics (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Irshad Ahmed HajamDepartment of Pediatrics, University of California San Diego, San Diego, CA 92093, USA.ORCID 0000-0003-4010-1845
George Y LiuDepartment of Pediatrics, University of California San Diego, San Diego, CA 92093, USA.

Funding

Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insightsR01AI181321 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Clarence Buddy Creech, George Y Liu · 2023 to 2026
$3.2M
Staphylococcus aureus interference with IsdB vaccinationR01AI144694 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIU, GEORGE Y · 2019 to 2023
$2.8M
Mechanisms of vaccine interference by S. aureus-induced imprintsR01AI179098 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI George Y Liu · 2024 to 2026
$2.2M
National Institute of Health R01AI127406National Institute of Health R01AI144694NIAID NIH HHS R01 AI144694NIAID NIH HHS R01 AI179098NIAID NIH HHS R01 AI181321
6 · The paper itself

Abstract

Vaccination arguably remains the only long-term strategy to limit the spread of

Indexed as

immune evasionimmune imprintingMRSAS. aureusvaccine interferencevaccines

Identifiers

PMID38786139
PMCPMC11117348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.